YKL-40 was found elevated in CSF from several acute and chronic neuroinflammatory conditions [15], as well as in preclinical and prodromal AD/mild cognitive impairment (MCI) [16,17,18]. This evidence concerns the gene CHI3L1 and Alzheimer disease.